Cmpx stock forecast.

Compass Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CMPX stock price.Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...

When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ... March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.

The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...

See CMPX Report. The 84 rating InvestorsObserver gives to Compass Therapeutics Inc. ( CMPX) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 92 percent of stocks in the Healthcare sector, CMPX’s 84 overall rating means the stock scores better than 84 of all stocks. CMPX has an Overall Score of 84.$10.50 (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a …CMPX : 3.36 (+8.74%) Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Globe Newswire - Mon Mar 21, 2022. Ended 2021 with $144.5 million in cash and cash equivalentsCTX-009 (DLL4 X VEGF-A bispecific antibody) Global Phase 2 study in patients with advanced... Find the latest argenx SE (ARGX) stock quote, history, news and other vital information to help you with your stock trading and investing.

According to the issued ratings of 1 analysts in the last year, the consensus rating for Kamada stock is Buy based on the current 1 buy rating for KMDA. The average twelve-month price prediction for Kamada is $11.00 with a high price target of $11.00 and a low price target of $11.00. Learn more on KMDA's analyst rating history.

About Compass Therapeutics. Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth.

The average Mind Medicine stock price prediction forecasts a potential upside of 810.6% from the current MNMD share price of $3.02. What is MNMD's forecast return on equity (ROE) for 2023-2026? (NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ...Stock Price Forecast. The 28 analysts offering 12-month price forecasts for APA Corp (US) have a median target of 48.50, with a high estimate of 65.00 and a low estimate of 34.00. The median ... The average TRACON Pharmaceuticals stock prediction of $12.40 implies an upside potential of 392.1% to current levels for this stock.Compass Therapeutics (NASDAQ: CMPX)Compass Therapeutics ...Stock price analysis for Compass Therapeutics, Inc. (CMPX), stock quote, stock research, rsi, macd, support, resistance and most important highlights.

The Eterna Therapeutics 52-week low stock price is 0.84, which is 31.1% below the current share price. ... Compass Therapeutics (CMPX), United States, $0.215B ...Abstract. Biogenic secondary organic aerosols (SOAs) contribute to a large fraction of fine aerosols globally, impacting air quality and climate. The formation of biogenic SOA depends on not only emissions of biogenic volatile organic compounds (BVOCs) but also anthropogenic pollutants including primary organic aerosol, sulfur dioxide (SO2), and …5 brokers have issued 12 month target prices for Zura Bio's stock. Their ZURA share price targets range from $10.00 to $22.00. On average, they predict the company's stock price to reach $16.60 in the next twelve months. This suggests a possible upside of 257.0% from the stock's current price.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.LGVN Stock 12 Months Forecast. $8.00. (314.51% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Longeveron in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 314.51% change from the last price of $1.93.Compass Therapeutics, Inc. Common Stock (CMPX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.

500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77

The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.GLTO Stock 12 Months Forecast. $5.67. (808.65% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Galecto in the last 3 months. The average price target is $5.67 with a high forecast of $10.00 and a low forecast of $2.00. The average price target represents a 808.65% change from the last price of $0.62.This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ...Tutorial video for Capsim business simulation. In this video, I take you on a step-by-step demonstration on how you can do Forecasting, Marketing, and Produc...NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesNov 10, 2023 · Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ...

Find the latest performance data chart, historical data and news for NASDAQ Composite Index (COMP) at Nasdaq.com.

Compass Therapeutics (NASDAQ: CMPX) is owned by 70.34% institutional shareholders, 11.41% Compass Therapeutics insiders, and 18.26% retail investors. Thomas J. Schuetz is the largest individual Compass Therapeutics shareholder, owning 5.98M shares representing 4.69% of the company.

With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.A high-level overview of CompX International Inc. (CIX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Nov 10, 2023 · Over. the last year, executives and large shareholders at CMPX have bought more shares than they have sold.Thomas J. Schuetz, CHIEF EXECUTIVE OFFICER of CMPX, was the latest CMPX insider to buy. They bought $33,700.00 worth of CMPX stock on Mar 10, 2023.Learn more about who owns CMPX stock here. Can I rely on CMPX as an income stream? Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.Apple Inc. Common Stock. $180.07 -0.12 -0.07%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs ...Find the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.After a massive correction of 61% YTD, CMPX stock looks deeply undervalued and is poised for a strong reversal rally. As an overview, Compass is a clinical-stage oncology-focused company that’s ...All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ...

The consensus price target of analysts on Wall Street is $2.50, which implies an increase of 83.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.50 and $2.50 respectively. As a result, VGZ is trading at a discount of -495.24% off the target high and -495.24% off the low.Overview News Ideas Financials Technicals Forecast CMPX chart Today 2.59% 5 days 2.06% 1 month 3.66% 6 months −31.25% Year to date −61.10% 1 year −34.44% 5 years …The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...The development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...Instagram:https://instagram. where to buy verano stockare kennedy half dollars valuablevoovaluable old quarters Ford pegged the cost of the six-week UAW strikes at $1.7 billion, more than rival GM's $1.1 billion estimate, while issuing an updated 2023 profit forecast. STOCKS CRM why is tesla down todaypenny stock broker According to data compiled by TipRanks on 24 March 2023, the consensus analyst forecast for Amazon stock price was bullish. A total of 37 out of 38 analysts rated the stock as a buy, while one gave it a hold rating. The consensus AMZN stock forecast for the next 12 months stood at $136.86 a share. Meanwhile, the highest Amazon stock …The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors? free day trading courses Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ...66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48.